Last: | $137.55 |
---|---|
Change Percent: | 0.51% |
Open: | $136 |
Close: | $137.55 |
High: | $138.32 |
Low: | $134.95 |
Volume: | 1,566,421 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$137.55 | $136 | $137.55 | $138.32 | $134.95 | 1,566,421 | 04-24-2024 |
$136.7 | $135 | $136.7 | $138.91 | $133.11 | 2,088,321 | 04-23-2024 |
$130.09 | $128.75 | $130.09 | $131.21 | $128.3813 | 1,694,278 | 04-22-2024 |
$128.44 | $126.52 | $128.44 | $128.88 | $126.08 | 1,557,641 | 04-19-2024 |
$125.91 | $127.25 | $125.91 | $127.335 | $125.42 | 873,688 | 04-18-2024 |
$126.98 | $127.62 | $126.98 | $127.99 | $126.74 | 886,750 | 04-17-2024 |
$127.42 | $129.43 | $127.42 | $129.43 | $127.4 | 692,266 | 04-16-2024 |
$128.64 | $129.28 | $128.64 | $129.89 | $128.075 | 698,794 | 04-15-2024 |
$128.53 | $129.64 | $128.53 | $130.2962 | $128.27 | 720,163 | 04-12-2024 |
$130.02 | $132.28 | $130.02 | $132.5399 | $129.18 | 754,222 | 04-11-2024 |
$131.62 | $132.67 | $131.62 | $132.99 | $131.14 | 787,364 | 04-10-2024 |
$132.75 | $130.73 | $132.75 | $132.78 | $130.73 | 800,073 | 04-09-2024 |
$130.04 | $130.63 | $130.04 | $131.69 | $130.04 | 595,109 | 04-08-2024 |
$130.63 | $130.25 | $130.63 | $131.15 | $129.11 | 691,495 | 04-05-2024 |
$131.5 | $133.1 | $131.5 | $134.05 | $131.4 | 847,776 | 04-04-2024 |
$132.39 | $132.1 | $132.39 | $133.48 | $131.27 | 1,067,052 | 04-03-2024 |
$132.29 | $134.6 | $132.29 | $134.6 | $131.395 | 1,404,317 | 04-02-2024 |
$134.77 | $132.73 | $134.77 | $135.445 | $131.03 | 2,109,037 | 04-01-2024 |
$133.11 | $131.18 | $133.11 | $133.41 | $131.18 | 888,001 | 03-29-2024 |
$133.11 | $131.18 | $133.11 | $133.41 | $131.18 | 888,001 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Quest Diagnostics Incorporated Company Name:
DGX Stock Symbol:
NYSE Market:
2024-04-24 17:01:45 ET Quest Diagnostics has experienced positive revenue growth over the past three years, driven by acquisitions and the base business. Cost structures have remained steady, with a slight decrease in operating expenses. Management has focused on cost-cutting measures and new...
Tuesday, Quest Diagnostics Inc (NYSE:DGX) posted first-quarter adjusted EPS of $2.04, beating the consensus of $1.86. Sales cam...
Kiniksa Pharmaceuticals Ltd. (KNSA) is expected to report $-0.14 for Q1 2024 Agree Realty Corporation (ADC) is expected to report $1.01 for Q1 2024 1st Colonial Bancorp Inc (FCOB) is expected to report for Q1 2024 Equity Residential of Beneficial Interest (EQR) is expected to report $...